• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Expansion and bioabsorption of the self-reinforced lactic and glycolic acid copolymer prostatic spiral stent.

作者信息

Laaksovirta S, Talja M, Välimaa T, Isotalo T, Törmälä P, Tammela T L

机构信息

Department of Urology, University Hospital and Medical School, University of Tampere, Tampere, Finland.

出版信息

J Urol. 2001 Sep;166(3):919-22.

PMID:11490246
Abstract

PURPOSE

Self-reinforced bioabsorbable stents can be made self-expanding due to the viscoelastic memory of the oriented bioabsorbable materials. A new self-expandable self-reinforced copolymer of lactic/glycolic acid, lactic/glycolic molar ratio 80:20 stent was developed to prevent postoperative urinary retention after procedures that induced prostatic edema. In in vitro experiments the expansion rate has been up to 100% during the first few hours at body temperature. We investigated the expansion rate and biodegradation of the self-reinforced lactic and glycolic acid copolymer prostatic spiral stent in vivo in the prostatic urethra.

MATERIALS AND METHODS

A total of 39 men, 52 to 84 years old, with lower urinary tract symptoms due to benign prostatic enlargement underwent interstitial laser coagulation of the prostate. A self-reinforced copolymer of lactic/glycolic acid, lactic/glycolic molar ratio 80/20 stent was inserted into the prostatic urethra at the end of the operation. The stent lumen diameter was 4.5 mm. The location and diameter of the lumen and degradation of the stent were studied with transrectal ultrasound at 1, 2, 4 and 6 months postoperatively. At 6 months patients underwent cystoscopy.

RESULTS

All except 1 patient voided on postoperative day 1. Mean lumen diameter was 7.4 mm. (range 6.2 to 8.2) at 1 month and 7.2 mm (range 6.2 to 7.5) at 2 months. At 4 months the stent was degraded into small pieces. No pieces of stent were found in the prostatic urethra on ultrasound or cystoscopy at 6 months. However, a portion of the spiral stent was found at the bottom of the bladder in 2 patients.

CONCLUSIONS

The speed and expansion rate of the self-reinforced copolymer of lactic/glycolic acid, lactic/glycolic molar ratio 80/20 stent was sufficient to lock the stent in place and ensure voiding in cases of edema induced bladder outlet obstruction. Strength retention greater than 2 months was long enough to avoid later impairments of voiding.

摘要

相似文献

1
Expansion and bioabsorption of the self-reinforced lactic and glycolic acid copolymer prostatic spiral stent.
J Urol. 2001 Sep;166(3):919-22.
2
Interstitial laser coagulation and biodegradable self-expandable, self-reinforced poly-L-lactic and poly-L-glycolic copolymer spiral stent in the treatment of benign prostatic enlargement.
J Endourol. 2002 Jun;16(5):311-5. doi: 10.1089/089277902760102811.
3
Rabbit muscle and urethral in situ biocompatibility properties of the self-reinforced L-lactide-glycolic acid copolymer 80: 20 spiral stent.自增强型丙交酯-乙交酯共聚物80:20螺旋支架在兔肌肉和尿道中的原位生物相容性特性
J Urol. 2002 Mar;167(3):1527-31.
4
Biodegradable self-reinforced polyglycolic acid spiral stent in prevention of postoperative urinary retention after visual laser ablation of the prostate-laser prostatectomy.
J Urol. 1995 Dec;154(6):2089-92.
5
Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study.可生物降解编织聚乳酸-乙醇酸共聚物尿道支架联合度他雄胺治疗良性前列腺增生所致急性尿潴留:一项初步研究。
BJU Int. 2009 Mar;103(5):626-9. doi: 10.1111/j.1464-410X.2008.08111.x. Epub 2008 Oct 16.
6
A randomized study to compare biodegradable self-reinforced polyglycolic acid spiral stents to suprapubic and indwelling catheters after visual laser ablation of the prostate.
J Urol. 1997 Jan;157(1):173-6.
7
The biodegradable self-reinforced poly-DL-lactic acid spiral stent compared with a suprapubic catheter in the treatment of post-operative urinary retention after visual laser ablation of the prostate.
Br J Urol. 1997 Sep;80(3):439-43. doi: 10.1046/j.1464-410x.1997.00308.x.
8
Biocompatibility properties of a new braided biodegradable urethral stent: a comparison with a biodegradable spiral and a braided metallic stent in the rabbit urethra.新型编织可生物降解尿道支架的生物相容性特性:与可生物降解螺旋支架及编织金属支架在兔尿道中的比较。
BJU Int. 2006 Apr;97(4):856-9. doi: 10.1111/j.1464-410X.2006.06000.x.
9
A randomised study to evaluate the efficacy of a biodegradable stent in the prevention of postoperative urinary retention after interstitial laser coagulation of the prostate.一项评估可生物降解支架预防前列腺间质激光凝固术后尿潴留疗效的随机研究。
Scand J Urol Nephrol. 2000 Aug;34(4):262-6. doi: 10.1080/003655900750042004.
10
Long-term outcome of prostatic stent treatment for benign prostatic hyperplasia.前列腺支架治疗良性前列腺增生的长期疗效
Urology. 1996 Oct;48(4):589-93. doi: 10.1016/S0090-4295(96)00327-5.

引用本文的文献

1
Prostatic stents: a narrative review of current evidence.前列腺支架:当前证据的叙述性综述
Ther Adv Urol. 2024 May 30;16:17562872241255262. doi: 10.1177/17562872241255262. eCollection 2024 Jan-Dec.
2
A scoping review of office-based prostatic stents: past, present, and future of true minimally invasive treatment of benign prostatic hyperplasia.基于办公室的前列腺支架的范围综述:良性前列腺增生真正微创治疗的过去、现在和未来。
World J Urol. 2023 Nov;41(11):2925-2932. doi: 10.1007/s00345-023-04508-7. Epub 2023 Jul 21.
3
Urethral stents in benign prostate hyperplasia.
Curr Urol Rep. 2003 Aug;4(4):282-6. doi: 10.1007/s11934-003-0085-0.